Breaking News

3 Big European Oil Companies Get Negative Outlook From S&P Over Price of Crude
Tweet TWEET

Direction Change Ahead, What to Expect - Research & Analysis on

Direction Change Ahead, What to Expect - Research & Analysis on
Achillion Pharmaceuticals, Inc. and Vertex Pharmaceuticals
Incorporated 
JAKARTA, INDONESIA -- (Marketwire) -- 11/13/12 --  Moments ago,
TradersInsight.net introduced new coverage of Achillion
Pharmaceuticals, Inc. (NASDAQ: ACHN) and Vertex Pharmaceuticals
Incorporated (NASDAQ: VRTX). Full outlook, analysis and consensus
opinion is available to readers via the links
below. 
www.TradersInsight.net/r/cnbc/7f00_ACHN 
www.TradersInsight.net/r/cnbc/0c25_VRTX 
The consistent delivery of accurate analyses relies solely on two
factors, namely: market awareness and industry insight. Recent market
drivers include grim European forecasts with Germany's growth
prospects signaling potential trouble ahead, headlines of "fiscal
cliff" concerns with potential friction between Republicans and
Democrats regarding upcoming expiration of tax cuts and recent
effects of Hurricane Sandy still affecting major areas. When it comes
to discovering the right edge at the right time, all these factors
play into effect. For a deeper understanding of the mechanics behind
these events and how it can affect your portfolio, please refer to
our email newsletter delivered to your inbox. 
Traders Insight is releasing new coverage on Achillion
Pharmaceuticals, Inc. for its current position within the consumer
durables sector. Achillion Pharmaceuticals, Inc. is a
biopharmaceutical company focused on the discovery, development and
commercialization of treatments for infectious diseases. The Company
is engaged in the development of antivirals for the treatment of
chronic hepatitis C infection (HCV), and the development of
antibacterials for the treatment of resistant bacterial infections. A
copy of this report featuring Achillion Pharmaceuticals, Inc.
(NASDAQ: ACHN) is available at:
www.TradersInsight.net/r/cnbc/7f00_ACHN. 
Traders Insight has released research on Vertex Pharmaceuticals
Incorporated for its changing role within the consumer durables
sector. Vertex Pharmaceuticals Incorporated (Vertex) is in the
business of discovering, developing, manufacturing and
commercializing small molecule drugs for the treatment of serious
diseases. To access the full research report on Vertex
Pharmaceuticals Incorporated (NASDAQ: VRTX) we welcome investors to
visit: www.TradersInsight.net/r/cnbc/0c25_VRTX. 
About Traders Insight
 Find direction and insight with
TradersInsight.net. Our model of enabling open collaboration between
members is breaking new ground into the investment community. By
tapping into the resources of the community, we are crowd-sourcing
our reach. As a result - we have been able to identify some of the
greatest moving companies on the market today. The evidence is in the
results, join today and experience what you've been missing. 
Contact: 
Cora S. Patton
press@TradersInsight.net
www.TradersInsight.net 
 
 
Press spacebar to pause and continue. Press esc to stop.